Stroke, Ahead of Print. Global and local (“glocal”) disparities in stroke incidence, prevalence, care, and mortality are persistent, pervasive, and progressive. In particular, the disproportionate burden of stroke in people of African ancestry compared to most other racial/ethnic groups around the world has been long standing, is expected to worsen, and so far, has defied solution, largely because conventional risk factors likely account for less than half of the Black versus White disparity in stroke outcomes. While hypotheses such as a differential impact or inadequate evaluation of traditional risk factors by race have been suggested as potentially key factors contributing to lingering racial/ethnic stroke disparities, relatively understudied novel risk factors such as psychosocial stress, environmental pollution, and inflammation; and influences of the social determinants of health are gaining the most attention (and momentum). Moreover, it is increasingly recognized that while there is a lot still to understand, there needs to be a major shift from incessantly studying the problem, to developing interventions to resolve it. Resolution will likely require targeting multilevel factors, considering contemporaneous cross-national and cross-continental data collection, creating scalable care delivery models, jointly addressing care quality and community drivers of stroke occurrence, incorporating policy makers in planning/dissemination of successful interventions, and investing in robust transdisciplinary research training programs that address the interrelated issues of health equity and workforce diversity, and regional capacity building. To this end, our international multidisciplinary team has been involved in conducting several epidemiological studies and clinical trials in the area of stroke disparities, as well as executing career enhancing research training programs in the United States and Africa. This award lecture paper shares some of the lessons we have learnt from previous studies, presents objectives/design of ongoing initiatives, and discusses plans for the future.
Risultati per: GPG: Versione 5.7.5 (Novembre 2021)
Questo è quello che abbiamo trovato per te
ESC 2021: diagnosi e trattamento dell’insufficienza cardiaca acuta e cronica (scompenso cardiaco acuto e cronico)
Sono stati pubblicati i “Dieci comandamenti” delle Linee guida ESC […]
GPG: Versione 5.7.6 (Dicembre 2021)
LE PRINCIPALI NOVITA’: INFLUSEARCH – Nuovo osservatorio di sorveglianza epidemiologica […]
Rilasciata la nuova versione dell'App VerificaC19 per la verifica della certificazione verde “rafforzata”
Comunicato del 05/12/2021 n°76
GPG: Versione 5.7.5 (Novembre 2021)
LE PRINCIPALI NOVITA’: INFLUSEARCH – Nuovo osservatorio di sorveglianza epidemiologica […]
GPG: Versione 5.7.4 (Novembre 2021)
LE PRINCIPALI NOVITA’: 1. “Nota 99 AIFA” con nuovi indicatori […]
GPG: Versione 5.7.3 (Settembre 2021)
LE PRINCIPALI NOVITA’: 1. Nuove “Patologie” con nuovi indicatori nella […]
[ESC 2021] Prevenzione delle malattie cardiovascolari nella pratica clinica
GPG: Versione 5.7.2 (Luglio 2021)
LE PRINCIPALI NOVITA’: 1. Nuova sezione in “GPG Network” –> […]
Gestione della multimorbilità e polifarmacoterapia 2021
GPG: Versione 5.7.1 (Giugno 2021)
LE PRINCIPALI NOVITA’: 1. Nuova sezione in “Vaccinazione” –> “Herpes […]
GPG: Versione 5.7.0 (Maggio 2021)
LE PRINCIPALI NOVITA’: 1. Nuova sezione in “Appropriatezza Terapeutica” –> […]
GPG: Versione 5.6.2.1 (Aprile 2021)
LE PRINCIPALI NOVITA’: 1. Aggiornamento e adeguamento del Modulo Vaccinazione […]
GPG: Versione 5.5.0 (16 Febbraio 2021)
LE PRINCIPALI NOVITA’: Migliorata DRASTICAMENTE la Velocità di navigazione all’interno […]